Page last updated: 2024-08-24

emtricitabine and Cancer of Liver

emtricitabine has been researched along with Cancer of Liver in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Funk, A; Gaertner, K; Krahn, I; Lin, L; Matthes, E; Sirma, H; von Janta-Lipinski, M; Will, H	1
Avci, A; Erhardt, A; Häussinger, D; Heintges, T; Lörke, J; Sagir, A	1
Averett, DR; Jansen, RW; Johnson, LC	1

Reviews

1 review(s) available for emtricitabine and Cancer of Liver

Article	Year
[New approaches in the treatment of hepatitis B]. Deutsche medizinische Wochenschrift (1946), 2004, May-21, Volume: 129, Issue:21 Topics: 2-Aminopurine; Adenine; Antiviral Agents; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Contraindications; Deoxycytidine; Emtricitabine; Famciclovir; Guanine; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Neoplasms; Organophosphonates; Organophosphorus Compounds; Polyethylene Glycols; Prodrugs; Prognosis; Recombinant Proteins; Tenofovir; Zalcitabine	2004

Article

Year

[New approaches in the treatment of hepatitis B].

Deutsche medizinische Wochenschrift (1946), 2004, May-21, Volume: 129, Issue:21

Topics: 2-Aminopurine; Adenine; Antiviral Agents; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Contraindications; Deoxycytidine; Emtricitabine; Famciclovir; Guanine; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Neoplasms; Organophosphonates; Organophosphorus Compounds; Polyethylene Glycols; Prodrugs; Prognosis; Recombinant Proteins; Tenofovir; Zalcitabine

2004

Other Studies

2 other study(ies) available for emtricitabine and Cancer of Liver

Article	Year
Strong and selective inhibitors of hepatitis B virus replication among novel N4-hydroxy- and 5-methyl-beta-L-deoxycytidine analogues. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7 Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Deoxycytidine; Dose-Response Relationship, Drug; Hepatitis B virus; HL-60 Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms; Molecular Structure; Nucleic Acid Synthesis Inhibitors; Time Factors; Transfection; Virus Replication	2007
High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:3 Topics: Antibody Specificity; Antiviral Agents; Base Sequence; Carcinoma, Hepatocellular; Cell Line; Emtricitabine; Growth Inhibitors; Hepatitis B virus; Humans; Liver Neoplasms; Molecular Sequence Data; Polymerase Chain Reaction; Virion; Zalcitabine	1993

Article

Year

Strong and selective inhibitors of hepatitis B virus replication among novel N4-hydroxy- and 5-methyl-beta-L-deoxycytidine analogues.

Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Deoxycytidine; Dose-Response Relationship, Drug; Hepatitis B virus; HL-60 Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms; Molecular Structure; Nucleic Acid Synthesis Inhibitors; Time Factors; Transfection; Virus Replication

2007

High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay.

Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:3

Topics: Antibody Specificity; Antiviral Agents; Base Sequence; Carcinoma, Hepatocellular; Cell Line; Emtricitabine; Growth Inhibitors; Hepatitis B virus; Humans; Liver Neoplasms; Molecular Sequence Data; Polymerase Chain Reaction; Virion; Zalcitabine

1993